Literature DB >> 25361764

Constitutive activation of MEK1 promotes Treg cell instability in vivo.

Jitao Guo1, Jianhua Zhang1, Xuejie Zhang1, Zhongmei Zhang1, Xundong Wei1, Xuyu Zhou2.   

Abstract

The instability of regulatory T (Treg) cells is involved in the pathogenesis of autoimmune diseases and also highlights safety concerns with regard to clinical Treg cell therapy. Cell-intrinsic molecular events linked to this Treg cell instability in vivo cells, which leads to safety concerns regardingare still obscure. Here we developed a novel luciferase-based reporter system and performed an unbiased screening for kinases that potentially modulate Foxp3 function. We found that the active form of COT/Tpl2 specifically inhibits the DNA binding activity of Foxp3 through a MEK-ERK-dependent pathway. Moreover, Treg cell-specific expression of activated MEK1 led to dysregulation of Treg function and instability of Foxp3 expression in vivo. Our results support the hypothesis that outside inflammatory signals act through the COT/Tpl2-MEK-ERK signaling pathway to destabilize the Treg lineage.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Autoimmunity; Cell Signaling; Immunology; Inflammation; T Cell; Treg Cell, Instability, Foxp3, COT, MEK, ERK

Mesh:

Substances:

Year:  2014        PMID: 25361764      PMCID: PMC4271203          DOI: 10.1074/jbc.M114.589192

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

2.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.

Authors:  Masahiro Ono; Hiroko Yaguchi; Naganari Ohkura; Issay Kitabayashi; Yuko Nagamura; Takashi Nomura; Yoshiki Miyachi; Toshihiko Tsukada; Shimon Sakaguchi
Journal:  Nature       Date:  2007-03-21       Impact factor: 49.962

3.  CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.

Authors:  Lequn Li; Wayne R Godfrey; Stephen B Porter; Ying Ge; Carle H June; Bruce R Blazar; Vassiliki A Boussiotis
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

4.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

5.  Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3.

Authors:  Kian Peng Koh; Mark S Sundrud; Anjana Rao
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

6.  T cell receptor signalling.

Authors:  J Lin; A Weiss
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

7.  COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

Authors:  Cory M Johannessen; Jesse S Boehm; So Young Kim; Sapana R Thomas; Leslie Wardwell; Laura A Johnson; Caroline M Emery; Nicolas Stransky; Alexandria P Cogdill; Jordi Barretina; Giordano Caponigro; Haley Hieronymus; Ryan R Murray; Kourosh Salehi-Ashtiani; David E Hill; Marc Vidal; Jean J Zhao; Xiaoping Yang; Ozan Alkan; Sungjoon Kim; Jennifer L Harris; Christopher J Wilson; Vic E Myer; Peter M Finan; David E Root; Thomas M Roberts; Todd Golub; Keith T Flaherty; Reinhard Dummer; Barbara L Weber; William R Sellers; Robert Schlegel; Jennifer A Wargo; William C Hahn; Levi A Garraway
Journal:  Nature       Date:  2010-11-24       Impact factor: 49.962

8.  Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells.

Authors:  S Constant; C Pfeiffer; A Woodard; T Pasqualini; K Bottomly
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

9.  DUSP6 regulates drug sensitivity by modulating DNA damage response.

Authors:  T V Bagnyukova; D Restifo; N Beeharry; L Gabitova; T Li; I G Serebriiskii; E A Golemis; I Astsaturov
Journal:  Br J Cancer       Date:  2013-07-09       Impact factor: 7.640

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

View more
  7 in total

Review 1.  Regulatory T cells turn pathogenic.

Authors:  Jitao Guo; Xuyu Zhou
Journal:  Cell Mol Immunol       Date:  2015-03-16       Impact factor: 11.530

2.  Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways.

Authors:  N A Zwang; R Zhang; S Germana; M Y Fan; W D Hastings; A Cao; L A Turka
Journal:  Am J Transplant       Date:  2016-05-23       Impact factor: 8.086

3.  Immune disease variants modulate gene expression in regulatory CD4+ T cells.

Authors:  Lara Bossini-Castillo; Dafni A Glinos; Natalia Kunowska; Gosia Golda; Abigail A Lamikanra; Michaela Spitzer; Blagoje Soskic; Eddie Cano-Gamez; Deborah J Smyth; Claire Cattermole; Kaur Alasoo; Alice Mann; Kousik Kundu; Anna Lorenc; Nicole Soranzo; Ian Dunham; David J Roberts; Gosia Trynka
Journal:  Cell Genom       Date:  2022-04-13

4.  Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.

Authors:  Xin Li; Nicole V Acuff; Angela R Peeks; Rebecca Kirkland; Kara D Wyatt; Tamas Nagy; Wendy T Watford
Journal:  J Biol Chem       Date:  2016-06-03       Impact factor: 5.157

Review 5.  Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.

Authors:  Lucy Wanjiru Njunge; Andreanne Poppy Estania; Yao Guo; Wanqian Liu; Li Yang
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

6.  Genetic screens reveal mechanisms for the transcriptional regulation of tissue-specific genes in normal cells and tumors.

Authors:  Ikrame Naciri; Marthe Laisné; Laure Ferry; Morgane Bourmaud; Nikhil Gupta; Selene Di Carlo; Anda Huna; Nadine Martin; Lucie Peduto; David Bernard; Olivier Kirsh; Pierre-Antoine Defossez
Journal:  Nucleic Acids Res       Date:  2019-04-23       Impact factor: 16.971

7.  Cnp Promoter-Driven Sustained ERK1/2 Activation Increases B-Cell Activation and Suppresses Experimental Autoimmune Encephalomyelitis.

Authors:  Marisa A Jeffries; Alison E Obr; Kelly Urbanek; Sharyl L Fyffe-Maricich; Teresa L Wood
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 5.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.